Company Filing History:
Years Active: 2022
Title: Lisette Sanders: Innovator in Veterinary Vaccines
Introduction
Lisette Sanders is a notable inventor based in Bergen, Netherlands. She has made significant contributions to the field of veterinary vaccines, particularly in the development of porcine vaccines against Porcine Circovirus Type 2 (PCV2) and associated diseases. Her innovative work has the potential to improve animal health and welfare.
Latest Patents
Lisette Sanders holds a patent for the recombinant expression of PCV2b ORF2 protein in insect cells. This invention addresses the need for effective veterinary vaccines by introducing a mutation in the PCV2b ORF2 protein. The mutation, which adds a Proline at amino acid position 131, prevents nuclear accumulation upon expression in insect cells. This advancement allows for efficient expression, easy harvesting, and the generation of large amounts of virus-like particles (VLPs). These VLPs are highly effective in vaccines aimed at reducing infection by PCV2 and alleviating associated signs of disease.
Career Highlights
Lisette works at Intervet Inc., a company dedicated to advancing veterinary medicine. Her research and innovations have positioned her as a key player in the development of effective vaccines for livestock.
Collaborations
Throughout her career, Lisette has collaborated with esteemed colleagues, including Paulus Jacobus Antonius Sondermeijer and Karin Huberdina Antonia Van Der Heijden-Liefkens. These partnerships have fostered a collaborative environment that enhances the research and development of veterinary solutions.
Conclusion
Lisette Sanders is a pioneering inventor whose work in veterinary vaccines is making a significant impact in the field. Her innovative approach to vaccine development is crucial for improving animal health and combating diseases in livestock.